The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy.
第一作者:
Angelo,Gámez-Pozo
第一单位:
Instituto de Genética Médica y Molecular (INGEMM) - IdiPAZ, Hospital La Paz, Madrid, Spain.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);乳腺肿瘤(Breast Neoplasms);基因表达谱(Gene Expression Profiling);基因组学(Genomics);人类(Humans);中年人(Middle Aged);突变(Mutation);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);回顾性研究(Retrospective Studies);幸存患者(Survivors);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases);时间因素(Time Factors);治疗失败(Treatment Failure)
DOI
10.1371/journal.pone.0109611
PMID
25330188
发布时间
2021-12-03
- 浏览23
PloS one
e109611页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



